Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
| ▸ | PLAU | P00749 | 4/20 | 0.47 |
| ▸ | HPN | P05981 | 4/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | MMP13 | P45452 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200245 | 1.00 | MMP2 (0.57) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL920895 | 0.99 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL11406948 | 0.99 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| Hydrochloric Acid SCHEMBL15537019 | 0.98 | MMP2 (0.55) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL1305743 | 0.89 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL1305745 | 0.89 | MMP2 (0.56) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL5490595 | 0.88 | PLAU (0.45) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL28509074 | 0.87 | MMP2 (0.60) | MMP2MMP9PLAUHPNITGB3 | |
| SCHEMBL20008635 | 0.87 | MMP9 (0.67) | MMP2MMP9ITGB3ITGA2BSLC1A3 | |
| SCHEMBL28212986 | 0.87 | MMP9 (0.67) | MMP2MMP9ITGB3ITGA2BSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 785 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680762-A1 | OSTOMY OUTPUT INDICATOR | HOLLISTER INCORPORATED (US) | 2026-01-21 | — | — | EP | claimed |
| EP-3557816-B1 | SELF-DIAGNOSIS METHOD FOR COMMUNICATION PROTOCOL OF SECURITY-LEVEL INSTRUMENTATION AND CONTROL SYSTEM OF NUCLEAR POWER PLANT | CHINA TECHENERGY CO LTD (CN) | 2026-01-14 | — | — | EP | claimed |
| US-12458582-B2 | Stabilized hyaluronic acid | CROMA-PHARMA GMBH (AT) | 2025-11-04 | — | — | US | claimed |
| US-20250281579-A1 | Methods and Compositions for Oral Administration of Proteins | ORAMED PHARMACEUTICALS INC (IL) | 2025-09-11 | — | — | US | claimed |
| US-20250145945-A1 | CULTURE MEDIA FOR CULTURING PLURIPOTENT STEM CELLS IN SUSPENSION | ACCELLTA LTD. (IL) | 2025-05-08 | — | — | US | claimed |
| CN-119313997-A | Safety monitoring method for production process of fused magnesia based on supervision matrix regression | 东北大学 | 2025-01-14 | — | — | CN | claimed |
| WO-2024192383-A1 | OSTOMY OUTPUT INDICATOR | HOLLISTER INCORPORATED (US) | 2024-09-19 | — | — | WO | claimed |
| EP-4427588-A2 | COMPOSITIONS FOR HEMOLYSIS AND COAGULATION REGULATION AND STABILIZATION OF EXTRACELLULAR VESICLES | Streck LLC (US) | 2024-09-11 | — | — | EP | claimed |
| CN-115119829-B | Compositions for the modulation of haemolysis and coagulation of extracellular vesicles and stabilization | 斯特雷克股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-20240216325-A1 | NUCLEAR FACTOR KAPPA B PATHWAY INHIBITION TO ARREST CALCIFIC AORTIC STENOSIS | CORNELL UNIVERSITY | 2024-07-04 | — | — | US | claimed |
| WO-2022072504-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES | HEALION BIO, INC. (US) | 2022-04-07 | — | — | WO | claimed |
| CN-114206214-A | Compositions, methods and systems for protein corona analysis of biological fluids and uses thereof | 禧尔公司 | 2022-03-18 | — | — | CN | claimed |
| EP-3946054-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | Seer, Inc. (US) | 2022-02-09 | — | — | EP | claimed |
| US-7914542-B2 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | NEOTRACT, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20090192439-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-07-30 | — | — | US | claimed |
| US-20090060977-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-03-05 | — | — | US | claimed |
| US-20090018523-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-01-15 | — | — | US | claimed |
| EP-1887976-A2 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | Neotract, Inc. (US) | 2008-02-20 | — | — | EP | claimed |
| US-20060276871-A1 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | EXPLORAMED NC2, INC. (US) | 2006-12-07 | — | — | US | claimed |
| WO-2006127431-A2 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2006-11-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458582-B2 | Stabilized hyaluronic acid | CD44, HSPH1, ACR | MMP2 106/4885MMP9 133/4885PLAU 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.